Table 3.
The univariate sensitivity analysis.
| Parameter | Bound* | direct | societal |
|---|---|---|---|
| Base Case | 61.3 | 193.2 | |
| Vaccine prices | lower | 62.9 | 197.4 |
| upper | 54.1 | 174.4 | |
| Wastage rate | lower | 61.4 | 193.6 |
| upper | 61.1 | 192.8 | |
| Administration costs | lower | 75.7 | 228.8 |
| upper | 44.3 | 147.4 | |
| Work loss for vaccination | lower | 61.3 | 212.8 |
| upper | 61.3 | 176.9 | |
| Pregnant woman Screening rate | lower | 64.3 | 200.9 |
| upper | 60.1 | 190.3 | |
| Screening sensitivity and specificity | lower | 54.9 | 176.1 |
| upper | 63.7 | 199.8 | |
| Screening cost | lower | 70.5 | 216.4 |
| upper | 54.2 | 174.6 | |
| Coverage rate | lower | 60.2 | 190.4 |
| upper | 61.3 | 193.2 | |
| Vaccine Efficacy | lower | 56.8 | 179.0 |
| upper | 62.6 | 197.7 | |
| Prenatal infection rate in HBsAg positive mother | lower | 60.9 | 190.8 |
| upper | 61.5 | 194.6 | |
| HBIG injection rate | lower | 61.2 | 193.1 |
| upper | 61.3 | 193.3 | |
| HBIG prices | lower | 64.5 | 201.6 |
| upper | 54.9 | 176.6 | |
| HBV infection rate in pregnant woman | lower | 61.4 | 192.1 |
| upper | 61.1 | 194.6 | |
| Costs of health outcomes | lower | 30.8 | 161.5 |
| upper | 128.1 | 256.9 | |
| Discount rate | lower | 142.6 | 278.6 |
| upper | 41.3 | 172.5 |